Description

FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of the indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for various central nervous system disorders, including chronic pain, fibromyalgia, and irritable bowel syndrome. It has a strategic alliance agreement with SciCann Therapeutics Inc. for the production and distribution of cannabinoid-based, patent pending, and indication-specific products; and a collaborative research and development agreement with Solarvest BioEnergy Inc. to develop algae-based pharma-grade cannabinoids. FSD Pharma Inc. is headquartered in Cobourg, Canada.

Description

Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines for the treatment of liver diseases in the United States. Its product candidate includes Emricasan, an orally active caspase protease inhibitor that is in Phase IIb clinical trials for a post-orthotopic liver transplant as a result of hepatitis C virus infection with a sustained viral response; for portal hypertension; for liver fibrosis caused by nonalcoholic steatohepatitis; and for liver function. The company is also developing CTS-2090, an orally active inhibitor of caspase 1, which is in the preclinical development stage for treating chronic diseases involving inflammasome pathways. The company has a collaboration agreement with Novartis to conduct three Phase IIb clinical trials. Conatus Pharmaceuticals Inc. was founded in 2005 and is headquartered in San Diego, California.

Description

Dougherty’s Pharmacy, Inc. focuses on acquiring, managing, and growing community-based pharmacies in the Southwest Region of the United States. Its flagship store is Dougherty’s Pharmacy, a turn-key multi-service pharmacy located in Dallas, Texas. The company was formerly known as Ascendant Solutions, Inc. and changed its name to Dougherty’s Pharmacy, Inc. in May 2017. Dougherty’s Pharmacy, Inc. was founded in 1929 and is based in Dallas, Texas.

Description

Vivakor, Inc., a technology and asset acquisition company, procures, develops, and commercializes various assets in the natural resources sector worldwide. It engages in the oil extraction activities from the sallow oil-laden areas in Eastern Utah. The company owns land in the area located near Vernal, Utah. It is also involved in the extraction of precious metals. The company has 18 sizable metals mineral reserves in the Western United States. The company was founded in 2006 and is based in Las Vegas, Nevada.

Description

Medifirst Solutions, Inc., a development stage company, focuses on developing products within the healthcare market for consumer and professional applications. It develops a hand-held mobile laser system, The Time Machine Series lasers to treat temporary relief of minor muscle and joint pains, stiffness, minor arthritis pain, muscle spasms, temporary increase in local blood circulation, and temporary relaxation of muscles. Medifirst Solutions, Inc. was founded in 2010 and is based in Freehold, New Jersey.

Description

Imagin Medical Inc. engages in developing imaging solutions for the early detection of cancer through the use of endoscopes. Its ultrasensitive imaging technology is based on improved optical designs and advanced light sensors for detecting cancer, as well as visualize, identify, and remove cancerous cells. The company’s target market is bladder cancer. Imagin Medical Inc. is headquartered in Vancouver, Canada.

Description

Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver an artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. It also offers the Argus II Retinal Prosthesis System for treating retinitis pigmentosa. The company was founded in 1998 and is headquartered in Sylmar, California.

N